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2Abstract
Background: Despite advances in treatment of pain in advanced cancer, it remains a major
source of suffering with adverse effects on patients’ life quality. There is increasing
understanding of its multi-dimensional nature and the variable responsiveness of
medication to complex pain. Less clear is how patients and their caregivers respond to, and
manage pain complexity.
Aim: To explore patients’ and carers’ experiences of advanced cancer pain and the
processes that they engage in to manage pain.
Design: Qualitative study employing face-to-face interviews at two time points and audio-
diaries. Data were analysed using grounded theory strategies.
Setting/participants: Purposive sample of 21 advanced cancer patients and 16 carers from
oncology outpatients in a tertiary cancer centre and a hospice.
Results: Three distinct patterns of pain were discerned in patients’ accounts, distinguishable
in terms of complexity, severity, transiency, and degree of perceived control over pain.
Pain was dynamic reflecting changes in the disease process, access to, and effectiveness of
pain relief. For patients’ and carers’, neither pain relief nor expertise in pain management is
secured once and for all. The main drivers of help-seeking and action by patients to
manage pain were: the sensory experiences of pain and meaning attached to it; not beliefs
about analgesia.
Conclusions: The complex and dynamic nature of pain and how it was understood shaped
help-seeking and pain management. Variable effectiveness of pain relief for different pain
types were challenging for patients and professionals in achieving relief.
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What is already known about the topic?
x Advanced cancer pain is still reported as common, severe, and undertreated
x Patients’ attitudes and beliefs impinge on use of medications, particularly morphine,
to manage pain
What this paper adds?
x The dynamic, complex and multi-dimensional nature of pain presents a major
challenge for patients and professionals to manage it and to secure good enough
relief
x Although attitudes and beliefs towards analgesics vary, they do not drive patient
behaviour. Rather, patients’ sensory experiences of pain, particularly severity, and
its meaning, shaped behaviour with consequences for how pain was managed
x The multidimensional nature of pain meant that many patients were taking a wide
range of pain medications i.e.: non-opioid analgesics, compound analgesics, slow
release opioids, and anticonvulsants. The acceptability of rescue morphine varied
depending on patients’ sensory experiences of pain
Implications for practice, theory or policy
x Pain management in advanced cancer is more accurately conceived of as a trial and
error process for patients and professionals
4x Clinicians should be aware of the use of rescue morphine in patients who are opioid
naïve
x There is need for longitudinal studies to examine transitions between pain states in
advanced cancer, how they are responded to by professionals and managed by
patients
5Introduction
Pain continues to be a major source of suffering in advanced cancer with adverse effects on
patients’ life quality1-3 and caregiver distress4-6. A meta-analysis of pain prevalence7 found a
rate of 64% among advanced cancer patients, of whom more than one third graded their
pain as moderate or severe. There is increasing recognition of the complexity and multi-
dimensionality of pain, varying in type, source, intensity, duration and site, experienced
singularly or in combination, and is imbued with meaning8. This includes different types of
pain such as neuropathic9, incident or breakthrough2, and bone pain10 associated with poor
pain control and with negative impact on physical, cognitive and social functioning and
mood. Further, since these types of pain are both disease and treatment related, expansion
of new treatment modalities that extend life, thus lengthening the advanced trajectory
stage, mean that prevalence of complex pain is likely to increase11. The meaning and
consequences of the multi-dimensional nature of pain in advanced cancer and the
differential responsiveness of varying types of pain to opioid analgesia 9,12 has not thus far
informed understanding of how patients manage their pain. Further, the lengthening of the
advanced cancer trajectory and increased risk of complex pain creates new challenges for
patients in managing it. However, from the perspective of patients, the literature typically
construes cancer pain as singular, linear, cumulative in nature, and inevitable as death
approaches13. At the same time, research interest has primarily focused on under-
treatment of cancer pain, and particularly on the attitudes and beliefs of patients that
impinge negatively on medication adherence generally and on morphine specifically13-15.
Reported in systematic reviews16, 17 and qualitative synthesis18, these include: fear of
addiction and side effects, the desire to be seen as a “good patient”, beliefs that pain
6signifies progression of the cancer and that pain is inevitable. The underpinning theory is
that attitudes and beliefs inform behaviour and lead to poor adherence to medication
regimens that in turn give rise to sub-optimal pain relief. While this theory has informed
research on educational interventions to tackle sub-optimal pain management practices, a
recent review of reviews concluded that although such interventions can have a very small
impact on pain intensity, their clinical significance is questionable19.
There appears to be a knowledge gap between the conception of pain in the medical
literature as complex and heterogeneous and the processes whereby patients with
advanced cancer experience, understand and manage pain in everyday life.
Aim
The aim of this study was to examine how patients with advanced cancer and their
caregivers experienced pain complexity, the meaning they attached to it, how they
managed it and what shaped their perspectives and actions. It thus provides insight into an
important theoretical and practical gap in current understanding of cancer pain.
Methods
We employed a qualitative interpretive approach. The study was conducted in two service
settings in a Northern English city: oncology outpatients’ clinics within a tertiary cancer
centre, and a hospice palliative care service, to include patients at different stages in the
disease course. It was part of a research programme on the management of advanced
cancer pain. Research ethics committee approval was obtained (National Research Ethics
Service (NRES) Committee South West – Cornwall & Plymouth; 12/SW/0287).
7Participants
Inclusion criteria were: experiencing pain, living at home, over the age of 25, with advanced
cancer (defined as active and non-curative). Purposive sampling was used to identify
patients at different points in the disease course with different types of cancer. Our
assumption was that recruiting patients from oncology and palliative care would ensure
inclusion of individuals at different points in the disease course. Patients were initially
approached by oncologists and research nurses from out-patient clinics in eight speciality
cancer areas (lung, breast, colorectal, head and neck, prostate, gynaecological, upper GI,
and renal); and by clinical nurse specialists for those receiving palliative care services.
Following expressions of interest, the first author (JH) discussed participation with
interested individuals in person or by telephone and obtained informed consent.
Data collection
In-depth, face-to-face interviews were carried out at two time points, six weeks apart to
capture change over time. These were a combination of dyadic (patients and their caregiver
together) and individual interviews, conducted primarily by JH, mainly in patients’ homes.
Dyadic interviews sought to explore the collective, inter-dependent perspective of patient
and caregiver in pain understanding and management20,21.
Interviews were guided conversations to elicit accounts of participants' experience in their
own words at a pace determined by them, using a topic guide (Appendix 1). This was used
flexibly as an aide memoire to discuss experience of illness and pain. Second interviews
incorporated specific prompts to pursue analytic ideas, for example, transitions in the pain
experience and how these were managed. A sub-sample of patients was selected based on
8their varied experiences of pain and asked to complete audio diary in-between interviews,
to obtain a contemporaneous picture of pain and the response to it.
Data analysis
Interviews and audio diaries were transcribed, and participants chose a pseudonym. Data
were collected from April 2013 - January 2014.
We adopted a grounded theory analytic approach22, 23. This combined concurrent data
collection and analysis with modification to the topic guide to pursue emerging lines of
inquiry. Debrief meetings involving the first two authors (JH &MG) took place and were
recorded after each interview. They provided space to reflect on the interview process,
emotional content, and effect on the researcher, and to explore initial ideas about the data.
Further phases carried out by JH & MG separately and together, were familiarisation
through multiple readings of transcripts; then open and focused coding and memo-writing
to facilitate the development of categories and concepts. Method of constant comparison
was used throughout whereby data segments and the developing codes and categories
were compared both within cases to identify the temporal sequencing of events, and how
these were understood and acted upon, and across cases to examine variation between
participants. For example, having developed the analytic categories of pain type and their
properties (complexity, intensity and controllability), we examined their consequences in
terms of subjective meaning and the work of pain management for patients and caregivers.
Throughout, data collection and analysis, data, codes and concepts were discussed within
the research team (of varied disciplinary backgrounds: psychology, sociology and academic
palliative care medicine); and with the wider steering group, including patient
representatives, clinicians and academics. NVivo10 was used to support the analysis.
9Results
Twenty-four patients and 18 carers were recruited. Of these, 16 patient/carer dyads and
five patients alone completed a first interview; three patients withdrew on account of
deteriorating illness. Eleven patient/carer dyads and three patients alone completed the
second interview; three had died and four were too unwell to participate. We did not seek
to interview caregivers following the death of their relative. Three patients completed the
audio diary. 35 interviews were conducted, (27 patient/caregiver dyads). Average interview
length was around an hour (range 45-130 minutes). Table 1 provides a profile of patients.
All were White British.
Insert table 1 here
Stage in advanced cancer
Although everyone had advanced cancer, the point of diagnosis and stage in the disease
process varied. Many were diagnosed with advanced cancer at, or within a short period of
their first contact with cancer services. The length of time that people had lived with
advanced cancer differed across cancer types. At one end of the spectrum were 5 patients
who were diagnosed between 2 weeks and 9 months prior to interview (renal, bowel,
ovarian and lung cancer); at the other were those who had lived with advanced cancer for
between 4 and 11 years (four patients all with prostate cancer); the remainder were in-
between (breast, head and neck, upper GI).
10
In characterising types and severity of pain, we have used participants' own accounts.
Typically, patients employed visceral language and metaphors to differentiate pain texture
and intensity.
1: Complex: multiple, severe and uncontrolled (8 patients)
Here, the multiple sources and types of pain, occurring simultaneously and cumulatively,
informed the complexity of the pain experience. Whereas morphine reduced some pain to
what was described as a constant 'dull ache', other types of pain - persistent and
intermittent - overlaid this with the distinctive features of neuropathic, inflammatory and
bony pain as described in the medical literature.
In my hips it’s a funny pain, it’s more of an ache not a pain, like a dull ache, it’s as
best I can describe it. This [points to shoulder blade] when I get it is like somebody
sticking a knife in you…Most strangest thing that puzzles me is my feet, my toes,
numb all the time, these 3, little toe next to it. It’s a weird feeling, I get completely
numb, I can touch it and you can’t feel it, it’s just completely dead, and then within 2
minutes its right, it’s annoying it’s not painful.
Graham, P21
For other patients, this type of 'nerve' pain was described as excruciating:
I feel like I had to bite on something to stop me screaming. It was ...like being
stabbed, as if I was being chopped up, like a red hot knife or poker in my legs and
knees...I was told it's because the tumour's pressing on a nerve...my left leg when I
touch it feels numb, like it belongs to someone else.
Betty, P6
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Where cancer had metastasised to the bone, common in patients with breast and prostate
cancer, 'bony' pain overlaid a constant 'dull ache' with an intensity that was uncontrolled by
strong opioids. At the first interview Jenny described new multiple pain sites:
I’ve lived with this pain in my side now for like 3 weeks and this in my shoulder for
nearly 4 weeks. And it’s so bad ...my skin just feels like somebody’s chucked hot water
at it, it’s, it’s just like with radiotherapy, just like burning... they say to me at the
hospital it’s probably the cancer ...that’s gone into that particular bone....
Jenny, P3
In her audio diary, she recounted how the x-ray revealed several rib fractures, resulting in
pain severity, "like a 10 plus" with the consequence that she didn't want to do anything or
go anywhere, couldn't sleep or lie down, and cried 'bucket loads' - from pain and associated
low mood. Whereas, her regular slow release opioids kept background pain to an ache, the
increased dosage of rescue morphine didn't touch this pain. Offered radiotherapy to relieve
it, Jenny reported in the second interview that the intensity had reduced somewhat. She
anticipated that similar type pain would emerge elsewhere.
Aspects of this pain experience was perceived as 'uncontrollable' in persistence and
severity, albeit all in this group when interviewed were using a combination of non-opioid
analgesics, compound analgesics, slow release opioids, rescue morphine, and
anticonvulsants.
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2: Complex: multiple, intermittently severe, partially controlled (8 patients)
The predominant feature of pain here was intermittent, oscillating pain, occurring at
unpredictable intervals, over a day or days, without identifiable triggers. A typical form of
this type of incident pain is illustrated below:
My pain I would say is moderate now...then I get these awful headaches...feels my
head is going to explode...and I take the Oromorph then...which helps...I have to
have a bottle of that always, otherwise I panic.
Angus, P2
Less typical was the form described by Ruth:
The pain in the middle of the stomach...It can come and go just as easy, and I've had
it last all day and all night...like a griping spasm...It comes to a climax for a second
...climaxes like a gripey pain and then it subsides and it makes all these squidgy
noises ...that varies as to how strong it is...can be excruciating...you don’t know
where to put yourself..., then 3 minutes later it’s doing it again and that can go on
anything up to 12 hours and then it just will go and I don’t know why, can’t follow a
pattern at all.
Ruth, P24
Sometimes, but not always, this type of incident pain was relieved with rescue morphine.
Lack of consistent experiential evidence that 'rescue morphine' worked, resulted to patients
and carers questioning its continued use for such pain.
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Typically, patients with this type of pain pattern were prescribed a combination of non-
opioid analgesia, slow release and rescue morphine, although actual use of the latter was
inconsistent.
3: Multiple, simultaneous, low severity, 'controlled' (5 Patients)
Here, pain intensity was overall low, but punctuated by occasional more intense pain. Such
a pattern was reported by patients in the early advanced cancer stage:
There’s 2 types really…sometimes I get a really sharp pain and the other sort of pain
is like a… well it’s more ache, a bit like a period pain actually...I feel it in my hips...like
pushing down when you're pregnant.
Nicole, P 14
Although Nicole was prescribed Paracetamols and codeine, both were only used when
needed, "sometimes Paracetamols' enough, but if it isn't I take a codeine".
This pain pattern was also present for patients who were near the end of life when pain was
not a major feature of the cancer. Whereas such patients might have experienced
considerable pain leading up to diagnosis and subsequently, fatigue and weakness, leading
to inactivity, meant that pain was not viewed as a problem now, although other symptoms
like sickness, diarrhoea or constipation were strongly manifest. Thus George, whose second
interview was around 5 weeks before his death, only got up for a couple of hours during the
day.
I can put myself completely out of pain by going and laying down.
George, P9
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At the time of interview analgesics for this group ranged from Paracetamols to weak
opioids, and rescue morphine. Several had been prescribed opioids during treatment or
post surgery, but had stopped as they considered they had no need of them. From second
interviews, it appeared that for some patients here, awareness of subtle shifts in the
intensity of intermittent pain were opening up the possibility that medication dose and type
might need to be reviewed.
The meanings of pain and help seeking behaviours
Patients discussed pain in terms of its physical, emotional, and existential dimensions, and
its impact on what they could do. Accounts of severe, persistent pain adversely affected
mood; and inability to secure relief exacerbated sense of loss of control. Pain that was
unpredictable had similar emotional impact. Complex pain in its different forms was
disruptive of routines that had already narrowed as a result of the cancer. Escalating pain as
well as change in type and/or source was perceived as indicative of disease progression;
signifying that life was time limited. The reality was that a new onset of pain at a different
site or an increase in severity was often sign of metastatic spread. Consequently pain was
embodied within conflicting emotions and uncertainties. For some patients, this was a
potential barrier to seeking support24.
Sometimes I leave the suffering to the end because I think if I go in with suffering
they’re going to find something else. Like my chest infection, I think I’ve got lung
cancer when I haven’t. Everything I think is connected to my cancer, so when I get
pain in an area I think this is it.
Jason, P1
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However, although Jason delayed talking about his pain with the oncologist until the point
that he could only walk with difficulty, this precipitated a referral to the hospice for support
with pain management.
But focus on pain and the possibility and hope of finding a new means of relieving it, could
also be a distraction from thoughts of death. At several points during the interview, Max's
wife, Eliza, asserted that they were concentrating on getting better pain relief; it was the
pain and not the cancer that was 'wiping him out'. When Eliza went out of the room for a
moment, he remarked:
I'll be honest ...I've not told Eliza...she'd get carried away. Since I started on this
cancer drug, I'm pretty sure in myself that my back pain has reduced.
Max, P7
At the same time, the association of palliative care with closeness to death was also a
barrier for some patients in receiving supportive care for pain.
Processes of pain management
While multiple types of medication delivered in different forms (fentanyl patches, capsule
and oral) were the mainstay of pain management for patients experiencing complex,
persistent, severe pain, pain wasn't managed in the sense of being controlled. Whereas
medication might reduce background pain to a 'dull ache', other types of pain were
perceived as unrelieved. Unrelieved pain included stabbing pain at unpredictable intervals
that could last for extended periods of time; crippling pain running up and down the legs
that eased only when sat or lay down; and pins and needles and numbness. Paradoxically,
the gap between the multiple types of pain medication and the lack of relief placed a
question mark over whether it was worth taking it.
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So if I did stop taking them, what would I be like? ...Ridiculous that, I could be twice
as bad...But obviously I take them because it’s erm, well I’ve been told to take them
by the hospital and the doctors so err I do, I do take them as and when I should do.
Bailey, P18
Patients additionally employed diverse non-pharmacological strategies to secure relief.
Betty massaged her legs which eased the pain a little; Dan tried spearmint drinks; Betty and
Jenny accessed Reiki at the hospice which although it didn't reduce the pain helped them to
feel better in themselves.
Patients also described a sense of helplessness at their inability to relieve the pain. Being
unable to do 'normal' things like get outside to the shops; potter in the garden; being with
others, affected well-being. The process whereby pain affected mood was spiral: sensory
experience contributed to low mood and inability to do things they enjoyed, and
exacerbated helplessness and despair. Caregivers also felt helpless and uncertain in face of
unrelieved pain. Dan's wife was torn between wanting to help and unsure as to whether
she was doing the right thing:
We do ... hot water bottles, in the middle of the night when he wakes in pain and
give him a tablet, so... I mean it’s hard because you’re frightened that you might just
give him too many... you see he’d take one, and pain doesn’t go , so I was worried of
giving another one and I’d say, “But you can’t have another one.” It’s like
Paracetamols, he’d take them and say, “Well can I have some more?” and I’m saying,
“No, you can’t take any more yet,” and of course he wor getting upset ‘cos he’s
saying that I wasn’t giving him his medication, You’re holding it back and I’d say: “No,
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I’m not.” So ...Yeah, ‘cos I mean you don’t like to see anybody in pain, but I just kept
thinking you can’t give him too much, else it might over... I mean I don’t know
whether it would have overdosed him or not, but it was...But it wor difficult dealing
with it, knowing how much to give him.
Hannah, C17
For patients with intermittently moderate to severe, partially controlled pain, non-opioid
analgesia and strong opioids were key resources in managing it. Patients also used
morphine to manage the rhythm of their day, to maximise what was most important to
them.
I know how much morphine to take now and to sleep..., my sleep comes first… it
might seem a waste to spend so much time asleep, but without that sleep then
there’s no life at all…I come here [day hospice] on a morning and then I have a sleep
on an afternoon and that way I can have a nice evening with my wife and with me
children.
Angus, P2
For patients with this pain pattern, rescue morphine was often the first opioid prescribed.
Although advised to use it 'as and when needed', dosage and frequency were a source of
uncertainty. Dick described 'swigging the bottle' during the night when pain severity
stopped him sleeping:
I'd no pain for 24 hours...but was sick every half hour for five hours after waking...it
was too easy to take.
18
Dick, P8
He subsequently negotiated with his doctor to go on regular morphine instead.
Side effects of rescue morphine, in context of intermittent pain, had the consequence that
use was limited or stopped.
I did take it [Oromorph] sometimes on a night when I was going to bed, but I thought
is it worth it? Because it gives me terrible nightmares, I didn’t like the nightmares. So
I thought well if I can stop taking that and it cures the nightmares, I would rather
have the pain.
Harry, P10
Similarly, feeling sleepy and dulled foggy thinking restricted use of rescue morphine in
conditions where slow release opioids were perceived as necessary to manage the pain.
Although our sample represented a range of different types of cancer and trajectories, our
data showed that it was the severity of pain that was the distinguishing characteristic which
posed implications and consequences for the processes which patients and their families
engaged in to manage it.
Discussion
Advanced cancer patients’ lives are shaped by their illness, demands of treatment, and
intrusive symptoms that affect what they can do, of which pain is among the most
prevalent7. Pain is complex, multidimensional and dynamic8-11. How this is experienced and
understood by patients and informs pain management practices including use of
medication, was focus of this study. We highlight three broad patterns of advanced cancer
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pain that illustrate the variability of pain at this stage. These demonstrate the dynamic,
complex, and non-linear nature of pain, and show how patients’ sensory experiences shape
the meaning of pain, the strategies employed to manage it and their perception of the
possibility of achieving control over pain with implications for life quality. For those with
severe pain, it was evident that the pain experience was not simply the consequence of
'non-adherence' to prescribed medication; it also reflected the uneven responsiveness of
pain complexity to medication, including strong opioids.
Pain complexity aligned with disease progression and the impact of treatments to extend
life mean that the pain experience is not static but dynamic; developing expertise in its
management is not a once off achievement for patients. Moreover, evaluating and
responding optimally to pain complexity also involves professionals in 'trial and error'
regarding particular combinations of pharmacological and other therapeutic options.
It was notable that even within a relatively short period of six weeks, changes occurred in
patients’ experience of pain. However, the existential meaning attached to cancer and
cancer pain, particularly the fear that pain signals disease progression could operate to
delay patients’ communication to professionals about it. Similarly, patients association of
palliative care with end of life could affect use of specialist pain management support.
Whilst our data showed the presence of a range of beliefs that are reported in the literature
as barriers to morphine16, 25-30, they were not central in driving behaviour. Within our
sample the majority of patients reported taking non-opioid analgesics, compound
analgesics, strong opioids and slow release opioids. However, the use of rescue morphine
varied depending on patients’ sensory experiences of pain. There were two sets of
circumstances in which intake of rescue morphine, although prescribed, was limited. One
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related to those patients who experienced moderate to severe incident pain which they
considered rescue morphine was not touching. The other was where patients either
considered their level of pain could be managed without the use of rescue morphine; or
introduced to opioids for the first time through this mode of delivery resulted in physical
and cognitive effects regarded as intolerable. For opioid naive patients31 particularly, their
experiences of adverse effects resulted in limited use or ended use, at least at this stage in
their pain. For those who were opioid tolerant but limited their intake of rescue morphine,
we posit that this was as a result of the permissiveness of rescue morphine and that there
was a lack of equilibrium in the trade-off between their perceived need for relief and side
effects11.
Limitations
Our study was conducted in one country and our sample consisted of one ethnic group,
therefore it may reflect a specific cultural perspective. However, being located in a tertiary
cancer centre with systems in place to effect transition to supportive care for symptom
relief alongside non-curative treatment, means that patients accessed multiple types and
combinations of pharmacological pain relief, as well as radiotherapy. There was
considerable overlap between patients recruited from oncology outpatients and palliative
care in their advanced cancer stage. This means our characterisation of pain complexity
may not exhaust the types of pain experience in advanced cancer, particularly the process of
transition and decision-making between pain states. Despite these limitations, this study
has important strengths. Patients in our sample represented a range of different cancer
types, ages, and both genders. They had varying levels of pain severity; experienced
different types and combinations of pain, from both singular and multiple sites; and used
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analgesics ranging from occasional paracetamol to a combination of strong opioids. The use
of in-depth longitudinal interviews and audio diaries provided us with a richer
understanding of the dynamic changes in pain over the illness trajectory32.
Conclusion
Advanced cancer pain is dynamic and complex. Patients (and caregivers) assume an active,
agentic role in managing pain. Beliefs about analgesics did not drive patient behaviour.
Instead, patients’ sensory experiences of pain, particularly of severity, and what they
perceived pain to mean, drove help seeking and action to manage pain. There are
challenges in securing pain relief in relation to different types of pain and their differential
responsiveness to medications.
There is a need for more longitudinal research to examine transitions between pain states in
advanced cancer, how these are responded to by services and managed by patients, thus
taking understanding of pain beyond pre-occupation with pain barriers.
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1Table 1: Patient characteristics
Pseudonym Age Gender Recruited
from:
Primary Tumour Site Diagnosed Diagnosis with
advanced
disease
Living situation Pain
Pattern
Jason 46 M Palliative Care Prostate & bone mets 2009 With spouse/partner 2
Angus 49 M Palliative Care Brain tumour 2011 With spouse/partner 2
Jenny 55 F Palliative Care Breast & bone mets 1997 2011 With spouse/partner 1
Eunice 73 F Palliative Care Breast; lung &brain mets 2010 2011 Alone 2
Betty 80 F Palliative Care Bowel; bone & pelvis mets 2013 Alone 1
Max 63 M Oncology Renal &prostate, metastatic 2012 2013 With spouse/partner 1
Dick 74 M Oncology Renal and bone mets 2011 With spouse/partner 2
George 69 M Oncology Bowel; liver & peritoneum mets 2012 With spouse/partner 3
Harry 66 M Oncology Lung (mesothelioma) 2013 With spouse/partner 2
April 76 F Oncology Ovarian 2013 With spouse/partner 3
Hannah 74 F Oncology Ovarian 2012 With spouse/partner 2
Nicole 48 F Oncology Ovarian 2008 With spouse/partner 3
Arthur 55 M Palliative Care Head and Neck (tonsil; liver 2009 2012 With spouse/partner 2
Winifred 74 F Oncology Upper GI; liver & lung mets. 2011 With spouse/partner 3
Dan 78 M Palliative Care Prostate, stomach & lung 2014 With spouse/partner 1
Bailey 67 M Oncology Prostate, bone mets. 2003 Alone 1
Roland 71 M Oncology Prostate, bone mets 2013 With spouse/partner 1
Patrick 78 M Oncology Prostate 2006 With spouse/partner 3
Graham 69 M Oncology Prostate, bone mets 2006 With spouse/partner 1
Richard 64 M Oncology Prostate, bone mets 2012 With spouse/partner 1
Ruth 74 F Oncology Upper GI 2010 2012 With spouse/partner 2
2
Appendix 1
Topic guide
Section Types of questions/prompts
Background Could you tell me a bit about yourself?
- Occupation
- living circumstances
- family
- children
- support system/network
Experience of cancer How long have you been poorly?
Diagnosis and treatment affected day to day life
Troublesome symptoms?
Medication/treatment regimen
Experience of pain Current experience of pain:
- sources
- types
- ongoing/intermittent
- predictable/unpredictable
- triggers
- typical day of pain
Managing pain Impact on day to day life
Type and dosage of pain medications
Regimen for pain
Effectiveness
Feelings about medication
Non-medication based strategies for pain management
Involvement and
communication with
health professionals
Current support:
- who
- why
- when
Accessibility
Engagement
Information, advice, and
support
Providing information and advice at diagnosis
- professional: generalist/specialist
- family/friends
Other sources
Providing information and advice about pain
Access additional information
Anything else that you would like to say?
